Literature DB >> 17220276

Genome maintenance defects in cultured cells and mice following partial inactivation of the essential cell cycle checkpoint gene Hus1.

Peter S Levitt1, Min Zhu, Amy Cassano, Stephanie A Yazinski, Houchun Liu, Joshua Darfler, Rachel M Peters, Robert S Weiss.   

Abstract

Cell cycle checkpoints are evolutionarily conserved signaling pathways that uphold genomic integrity. Complete inactivation of the mouse checkpoint gene Hus1 results in chromosomal instability, genotoxin hypersensitivity, and embryonic lethality. To determine the functional consequences of partial Hus1 impairment, we generated an allelic series in which Hus1 expression was incrementally reduced by combining a hypomorphic Hus1 allele, Hus1(neo), with either wild-type or null (Hus1(Delta1)) alleles. Primary Hus1(neo/Delta1) embryonic fibroblasts exhibited spontaneous chromosomal abnormalities and underwent premature senescence, while higher Hus1 expression in Hus1(neo/neo) cells allowed for normal proliferation. Antioxidant treatment almost fully suppressed premature senescence in Hus1(neo/Delta1) cultures, suggesting a critical role for Hus1 in oxidative stress responses. Treatment of Hus1(neo/neo) and Hus1(neo/Delta1) cells with the DNA adducting agent benzo(a)pyrene dihydrodriol epoxide resulted in a loss of cell viability that was associated with S-phase DNA damage checkpoint failure. Likewise, the DNA polymerase inhibitor aphidicolin triggered increased cell death, chromosomal aberrations, and H2AX phosphorylation, a marker for double-stranded DNA breaks, in Hus1(neo/neo) and Hus1(neo/Delta1) cultures compared to controls. Despite these pronounced genome maintenance defects in cultured Hus1(neo/Delta1) and Hus1(neo/neo) cells, mice of the same genotypes were born at expected frequencies and appeared grossly normal. A significant increase in micronucleus formation was observed in peripheral blood cells from Hus1(neo/Delta1) mice, but reduced Hus1 expression did not cause an elevated predisposition to spontaneous tumor development or accelerate tumorigenesis in p53-deficient mice. These results identify differential effects of altered Hus1 gene dosage on genome maintenance during in vitro culture, genotoxic stress responses, embryonic development, and adult homeostasis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17220276      PMCID: PMC1820507          DOI: 10.1128/MCB.01763-06

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  66 in total

1.  Structure-based predictions of Rad1, Rad9, Hus1 and Rad17 participation in sliding clamp and clamp-loading complexes.

Authors:  C Venclovas; M P Thelen
Journal:  Nucleic Acids Res       Date:  2000-07-01       Impact factor: 16.971

Review 2.  The DNA damage response during DNA replication.

Authors:  Dana Branzei; Marco Foiani
Journal:  Curr Opin Cell Biol       Date:  2005-10-13       Impact factor: 8.382

Review 3.  Genetic instability and darwinian selection in tumours.

Authors:  D P Cahill; K W Kinzler; B Vogelstein; C Lengauer
Journal:  Trends Cell Biol       Date:  1999-12       Impact factor: 20.808

4.  Targeted disruption of the cell-cycle checkpoint gene ATR leads to early embryonic lethality in mice.

Authors:  A de Klein; M Muijtjens; R van Os; Y Verhoeven; B Smit; A M Carr; A R Lehmann; J H Hoeijmakers
Journal:  Curr Biol       Date:  2000-04-20       Impact factor: 10.834

5.  The two DNA clamps Rad9/Rad1/Hus1 complex and proliferating cell nuclear antigen differentially regulate flap endonuclease 1 activity.

Authors:  Erica Friedrich-Heineken; Magali Toueille; Barbara Tännler; Christine Bürki; Elena Ferrari; Michael O Hottiger; Ulrich Hübscher
Journal:  J Mol Biol       Date:  2005-09-27       Impact factor: 5.469

6.  Aberrant cell cycle checkpoint function and early embryonic death in Chk1(-/-) mice.

Authors:  H Takai; K Tominaga; N Motoyama; Y A Minamishima; H Nagahama; T Tsukiyama; K Ikeda; K Nakayama; M Nakanishi; K Nakayama
Journal:  Genes Dev       Date:  2000-06-15       Impact factor: 11.361

7.  Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint.

Authors:  Q Liu; S Guntuku; X S Cui; S Matsuoka; D Cortez; K Tamai; G Luo; S Carattini-Rivera; F DeMayo; A Bradley; L A Donehower; S J Elledge
Journal:  Genes Dev       Date:  2000-06-15       Impact factor: 11.361

8.  ATR disruption leads to chromosomal fragmentation and early embryonic lethality.

Authors:  E J Brown; D Baltimore
Journal:  Genes Dev       Date:  2000-02-15       Impact factor: 11.361

9.  ATR, Claspin and the Rad9-Rad1-Hus1 complex regulate Chk1 and Cdc25A in the absence of DNA damage.

Authors:  Claus Storgaard Sørensen; Randi G Syljuåsen; Jiri Lukas; Jiri Bartek
Journal:  Cell Cycle       Date:  2004-07-13       Impact factor: 4.534

10.  The mouse genomic instability mutation chaos1 is an allele of Polq that exhibits genetic interaction with Atm.

Authors:  Naoko Shima; Robert J Munroe; John C Schimenti
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

View more
  13 in total

Review 1.  A tough row to hoe: when replication forks encounter DNA damage.

Authors:  Darshil R Patel; Robert S Weiss
Journal:  Biochem Soc Trans       Date:  2018-12-04       Impact factor: 5.407

2.  Targeted deletion of mouse Rad1 leads to deficient cellular DNA damage responses.

Authors:  Chunbo Zhang; Yuheng Liu; Zhishang Hu; Lili An; Yikun He; Haiying Hang
Journal:  Protein Cell       Date:  2011-06-02       Impact factor: 14.870

3.  HUS1 regulates in vivo responses to genotoxic chemotherapies.

Authors:  G Balmus; P X Lim; A Oswald; K R Hume; A Cassano; J Pierre; A Hill; W Huang; A August; T Stokol; T Southard; R S Weiss
Journal:  Oncogene       Date:  2015-04-27       Impact factor: 9.867

4.  Proteomic dissection of cell type-specific H2AX-interacting protein complex associated with hepatocellular carcinoma.

Authors:  Xiaoli Yang; Peng Zou; Jun Yao; Dong Yun; Huimin Bao; Ruyun Du; Jing Long; Xian Chen
Journal:  J Proteome Res       Date:  2010-03-05       Impact factor: 4.466

5.  Dual inactivation of Hus1 and p53 in the mouse mammary gland results in accumulation of damaged cells and impaired tissue regeneration.

Authors:  Stephanie A Yazinski; Peter M K Westcott; Kelly Ong; Jan Pinkas; Rachel M Peters; Robert S Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-16       Impact factor: 11.205

6.  Disease severity in a mouse model of ataxia telangiectasia is modulated by the DNA damage checkpoint gene Hus1.

Authors:  Gabriel Balmus; Min Zhu; Sucheta Mukherjee; Amy M Lyndaker; Kelly R Hume; Jaesung Lee; Mark L Riccio; Anthony P Reeves; Nathan B Sutter; Drew M Noden; Rachel M Peters; Robert S Weiss
Journal:  Hum Mol Genet       Date:  2012-05-09       Impact factor: 6.150

7.  Mammalian BTBD12 (SLX4) protects against genomic instability during mammalian spermatogenesis.

Authors:  J Kim Holloway; Swapna Mohan; Gabriel Balmus; Xianfei Sun; Andrew Modzelewski; Peter L Borst; Raimundo Freire; Robert S Weiss; Paula E Cohen
Journal:  PLoS Genet       Date:  2011-06-02       Impact factor: 5.917

8.  Conditional inactivation of the DNA damage response gene Hus1 in mouse testis reveals separable roles for components of the RAD9-RAD1-HUS1 complex in meiotic chromosome maintenance.

Authors:  Amy M Lyndaker; Pei Xin Lim; Joanna M Mleczko; Catherine E Diggins; J Kim Holloway; Rebecca J Holmes; Rui Kan; Donald H Schlafer; Raimundo Freire; Paula E Cohen; Robert S Weiss
Journal:  PLoS Genet       Date:  2013-02-28       Impact factor: 5.917

9.  Role of DNA damage response pathways in preventing carcinogenesis caused by intrinsic replication stress.

Authors:  M D Wallace; T L Southard; K J Schimenti; J C Schimenti
Journal:  Oncogene       Date:  2013-08-26       Impact factor: 9.867

10.  Hypersensitivity of primordial germ cells to compromised replication-associated DNA repair involves ATM-p53-p21 signaling.

Authors:  Yunhai Luo; Suzanne A Hartford; Ruizhu Zeng; Teresa L Southard; Naoko Shima; John C Schimenti
Journal:  PLoS Genet       Date:  2014-07-10       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.